about
CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergiesClinical use of adjuvants in allergen-immunotherapy.Recent advances in the use of nanoparticles for allergen-specific immunotherapy.Mechanistic insight into the impact of nanomaterials on asthma and allergic airway disease.Oral immunotherapy using polymeric nanoparticles loaded with peanut proteins in a murine model of fatal anaphylaxis.A comparison of nanoparticullate CpG immunotherapy with and without allergens in spontaneously equine asthma-affected horses, an animal model.
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Is The Allergen Really Needed in Allergy Immunotherapy?
@en
Is The Allergen Really Needed in Allergy Immunotherapy?
@nl
type
label
Is The Allergen Really Needed in Allergy Immunotherapy?
@en
Is The Allergen Really Needed in Allergy Immunotherapy?
@nl
prefLabel
Is The Allergen Really Needed in Allergy Immunotherapy?
@en
Is The Allergen Really Needed in Allergy Immunotherapy?
@nl
P2093
P2860
P1476
Is The Allergen Really Needed in Allergy Immunotherapy?
@en
P2093
Gabriela Senti
Ludger Klimek
Martin F Bachmann
Philipp Schendzielorz
Thomas M Kündig
Wolfgang A Renner
P2860
P2888
P356
10.1007/S40521-014-0038-5
P577
2015-01-01T00:00:00Z